Patients’ characteristics,
Conditions
Interventions
Patients were randomly assigned to either propofol or midazolam sedation. In the propofol group,
after a starting dose of 0.5-
1 mg/kg,
propofol was intermittently titrated and given as 0.25-
0.5 mg/kg bolus until achieving conscious sedative level.,Patients were randomly assigned to either propofol or midazolam sedation. In the midazolam group,
after an initial dose of 1-
2.5 mg,
midazolam was repeated with 1-
2.5 mg bolus dose.
Active Comparator Drug,Active Comparator Drug
Propofol sedation ,Midazolam sedation
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Elective esophagogastroduodenoscopy with ASA class I-II and no severe comorbidity
Exclusion criteria
Exclusion criteria: Severe comorbidity ASA class III-IV Pregnancy and Lactating woman
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery time Since recovery room arrival to discharge Case record form | — |
Secondary
| Measure | Time frame |
|---|---|
| Direct cost analysis During procedure Direct cost of EGD and sedation drug | — |
Countries
Thailand
Contacts
Public ContactRungsun Rerknimitr
Division of gastroenterology, Department of medicine
Outcome results
None listed